The role of alloantibodies against human platelet antigen‐15 in multiply platelet transfused patients
The role of alloantibodies against human platelet antigen‐15 in multiply platelet transfused patients
复制标题
抗人血小板抗原-15同种抗体在多次血小板输注患者中的作用
DOI：
10.1111/trf.12455
复制
发表时间：
2014
期刊：
影响因子：
2.9
通讯作者：
S. Santoso
中科院分区：
文献类型：
--
作者：
M. Matsuhashi;N. Tsuno;S. Sone;Y. Mishima;Y. Nagura;N. Watanabe;T. Ikeda;K. Kashiwase;Shinya Fukuda;Takayuki Iriyama;H. Hyodo;T. Yamashita;Y. Kamei;S. Arai;M. Minami;T. Fujii;M. Kurokawa;M. Tozuka;Koki Takahashi;S. Santoso
几项研究记录了抗人血小板（PLT）抗原（HPA）-15抗体在同种免疫介导的血小板减少症中的作用，包括新生儿同种免疫性血小板减少症、PLT输血不应性（PTR）和高加索人的输血后紫癜。然而，日本人群中抗HPA-15与PTR的相关性尚不清楚。
Several studies have documented the role of antibodies against human platelet (PLT) antigen (HPA)‐15 in alloimmune‐mediated thrombocytopenia including neonatal alloimmune thrombocytopenia, PLT transfusion refractoriness (PTR), and posttransfusion purpura in Caucasian persons. However, the relevance of anti‐HPA‐15 in PTR among the Japanese population is still unclear.